Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis. The Australian Hepatitis C Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples